|
Index of reports
> Cases resulting in other serious reactions (86)
> Cases with Metrorrhagia (8)
Below is the selection of adverse event reports related to Aldactone (Spironolactone) that includes cases resulting in other serious reactions where reactions include metrorrhagia.
Adverse event in 46 year old female receiving Aldactone (Spironolactone)
Reported by a pharmacist from Japan on 2007-10-06
Patient: 46 year old female
Adverse reactions / side effects: Breast Swelling, Metrorrhagia
Suspect drug(s):
Aldactone (Spironolactone)
Other drugs received by patient: Gleevec; Lasix; Drug, Unspecified
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-06-08
Patient: female, weighing 57.3 kg (126.1 pounds)
Adverse reactions / side effects: Metrorrhagia
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Ascites
Omepral
Administration route: Oral
Indication: Reflux Oesophagitis
Other drugs received by patient: Soldactone; Lasix; Lasix; Urso 250; Glakay; Tagamet; Neuer; Hokunalin; Livact
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-05-29
Patient: female, weighing 57.3 kg (126.1 pounds)
Adverse reactions / side effects: Metrorrhagia
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Ascites
Omepral
Administration route: Oral
Indication: Reflux Oesophagitis
Other drugs received by patient: Soldactone; Lasix; Lasix; Urso 250; Glakay; Tagamet; Neuer; Hokunalin; Livact
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-05-23
Patient: female, weighing 57.3 kg (126.1 pounds)
Adverse reactions / side effects: Metrorrhagia
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Ascites
Soldactone
Administration route: Oral
Indication: Ascites
Start date: 2007-01-01
End date: 2007-04-01
Omepral
Administration route: Oral
Indication: Reflux Oesophagitis
Other drugs received by patient: Lasix; Lasix; Urso 250; Glakay; Tagamet; Neuer; Hokunalin; Livact
Adverse event in receiving Aldactone (Spironolactone)
Reported by a pharmacist from Japan on 2007-05-04
Patient:
Adverse reactions / side effects: Metrorrhagia
Suspect drug(s):
Aldactone
Administration route: Oral
Soldactone
Administration route: Oral
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-02-20
Patient: female, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Metrorrhagia
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Primary Hyperaldosteronism
Start date: 2006-11-17
End date: 2006-12-08
Aldactone
Administration route: Oral
Other drugs received by patient: Adalat
Adverse event in female receiving Aldactone (Spironolactone)
Reported by a physician from Japan on 2007-02-14
Patient: female, weighing 56.0 kg (123.2 pounds)
Adverse reactions / side effects: Metrorrhagia
Suspect drug(s):
Aldactone
Administration route: Oral
Indication: Primary Hyperaldosteronism
Start date: 2006-11-17
End date: 2006-12-08
Aldactone
Administration route: Oral
Other drugs received by patient: Adalat
Adverse event in 35 year old female receiving Aldactone (Spironolactone)
Reported by a pharmacist from Japan on 2007-01-16
Patient: 35 year old female
Adverse reactions / side effects: Menstruation Irregular, Metrorrhagia
Suspect drug(s):
Aldactone
Administration route: Oral
Aldactone
Dosage: daily dose:100mg
Administration route: Oral
Other drugs received by patient: Adalat
|
